Tower Research Capital LLC (Trc) Neuronetics, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.29 Billion
- Q1 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Neuronetics, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 3,629 shares of STIM stock, worth $15,423. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,629
Previous 243
1393.42%
Holding current value
$15,423
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
24 transactions
Others Institutions Holding STIM
# of Institutions
108Shares Held
19.5MCall Options Held
96.2KPut Options Held
58.4K-
Vanguard Group Inc Valley Forge, PA2.31MShares$9.8 Million0.0% of portfolio
-
Kent Lake Capital LLC Mill Valley, CA1.74MShares$7.39 Million1.44% of portfolio
-
Balyasny Asset Management LLC Chicago, IL1.42MShares$6.02 Million0.01% of portfolio
-
Ikarian Capital, LLC Dallas, TX1.1MShares$4.68 Million0.57% of portfolio
-
Masters Capital Management LLC Atlanta, GA1MShares$4.25 Million0.19% of portfolio
About Neuronetics, Inc.
- Ticker STIM
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 27,022,800
- Market Cap $115M
- Description
- Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...